A $5B Top-Up on a Record Refining Quarter, but at $108 Shell Has Reached Our Target: Downgrading to Hold

Results vs. Consensus

Q3 2026 Scorecard

¹ Each SHEL American Depositary Share represents two Shell plc ordinary shares. Shell reports Adjusted Earnings per share of $1.93 on an ordinary-share basis; the $3.86 ADS figure is the mechanical translation, shown because vendor EPS estimates are quoted per ADS. Guided ranges in the third column are the ones Shell published in its October 7 update note, three weeks before the print; the July ranges are graded separately under Operating Metrics below. The headline consensus is the independently compiled figure, as in prior quarters. Shell's own company-compiled consensus of $10,329M (21 analysts, published October 21) gives a 4.7% beat, and every segment beat its company-compiled line except Corporate, which was $20M worse. Per-ADS EPS estimates ranged from $3.36 to $3.67 across vendors; the table uses the most widely cited $3.54.

Year-Over-Year Comparison

Quarter-Over-Quarter Comparison

Assessment: Earnings

The print beat on every measure and most of the beat came from a refining margin that nearly doubled. Adjusted earnings of $10,814M were the highest of the five quarters we have covered, up 9.9% sequentially and 99.1% year-over-year and beat the independently compiled consensus of $9.92B by 9.0% and the company-compiled $10,329M by 4.7%. Income attributable to shareholders of $12,057M was higher still because of the $0.8B identified-items gain.

What is genuinely new is the composition. Three months ago, management pre-flagged four Q3 headwinds: softer chemical spreads, less trading in a calmer market, more turnarounds and a Lubricants hole from missing Pearl base oil. Every one of them arrived. Chemicals earned $103M against $354M, crude and products trading fell, LNG liquefaction dropped 4% on maintenance, and Lubricants volumes fell. Earnings rose anyway, because Products earned $3,751M on a $42/bbl indicative refining margin and Integrated Gas captured higher realised LNG prices. That is the opposite of the Bear 1 pattern: the trading layer in the largest trading segment went down, and the earnings went up on price.

That cuts both ways. A quarter with less trading in it is a cleaner quarter. It is also a more macro-dependent one, and the macro in question is a refining margin that management told us in the same breath was already coming down in October. We read the quarter as a high-quality print of a peak-cycle environment, not as a new base.

Assessment: Cash and the Balance Sheet

Free cash flow of $16,322M covered the $5.3B distributed 3.1 times. Net debt still fell only $2,021M, to $39,733M, and the reason is the lease line. Lease liabilities rose $4,520M in the quarter to $34,147M because index-linked vessel leases must be remeasured at spot freight rates under IFRS 16, and freight on some routes is up ten-fold. The release puts the non-cash portion of the quarter's $6.6B of lease additions at $5.4B. ARC also brought $2.5B of net debt and leases, $1.9B of which Shell repaid in September.

Strip the leases and the balance sheet is close to unlevered. Net debt excluding leases fell to $5,586M from $12,126M, gearing excluding leases is 2.7%, and reported gearing fell 210bp to 16.6% even after an acquisition. ARC itself lowered gearing by 0.8 percentage points because three quarters of the consideration was paid in shares.

Two cash items run the other way into Q4 and both are known. Shell has accrued $5.1B more adjusted tax than it has paid this year, and the CFO confirmed it will "catch up," with Norway's December payments named. Against that, the $2.4B German emissions-certificate payment that usually lands in Q4 has already been made. Neither moves the thesis; both matter for anyone reading the Q4 cash statement against this one.

Assessment: The July Commitments, Graded

The July note set ten items to grade. The two that carried our downgrade triggers both cleared. The buyback came in at $5.0B against a $3.0B floor. The 2027–2028 capital framework, which management did not restate in July, was restated in words this time: Shell "will absorb ARC into our existing CapEx guidance," with numbers deferred to February 4. The capex test also improved at the margin, because full-year 2026 spending was cut by $1B. The one clear failure is working capital: the $7.7B that had not come back by June did not come back in Q3 either, and the nine-month outflow is now $8,372M. At Brent near $110 that is a price effect, not a collection problem, and it no longer governs the distribution. The full checklist sits in the Thesis Scorecard below.

Segment Performance

Segment Adjusted Earnings include non-controlling interest; the group figure excludes it, so the segment column sums to $10,829M against a group $10,814M ($14M of NCI plus rounding). Integrated Gas cash capital expenditure includes the $3.3B cash consideration for ARC.

Integrated Gas

Adjusted earnings of $3,037M rose 12.9% sequentially and 41.7% year-over-year. The company's bridge is unusually clean: higher volumes added $360M, realised prices and trading combined added $324M, and operating expenses took $180M. Production rose 22% to 772 kboe/d, mainly because of ARC, which completed on September 2 and contributed one month. Liquids production rose to 93 kb/d from 37 kb/d, the ARC condensate. LNG liquefaction fell 4% to 7.43Mt on planned maintenance, while LNG sales volumes rose 7.2% to 19.25Mt.

Identified items included a $1,290M post-tax impairment reversal on a North American asset, which the notes tie to changed commercial terms and the LNG Canada Phase 2 final investment decision. Cash capital expenditure of $4,756M includes the ARC cash consideration.

"This acquisition complements our existing footprint in Canada, strengthening our resource base for decades to come." — Sinead Gorman, Chief Financial Officer

Assessment: the segment earned more on price, volume and a bigger asset base at the same time, which is the cleanest Integrated Gas quarter of the year. The volume step is still ahead of us: the Q4 guide of 1,080–1,180 kboe/d carries a full quarter of ARC and compares with 631 kboe/d in Q2. The Qatari volumes remain outside the run-rate, and management said the LNG impact "will play into Q4 as well."

Upstream

Adjusted earnings of $3,189M fell 8.5% sequentially and rose 76.8% year-over-year. Three items explain the decline: $309M of higher well write-offs, $246M of unfavourable tax movements and $129M of lower realised liquids prices. A $341M favourable movement in unrealised profit eliminations offset part of it. Exploration expense was $661M against $110M in Q2, and total exploration well write-offs of $475M compare with roughly $0.3B flagged for Upstream in the October update note. Production of 1,802 kboe/d sat in the upper half of the 1,735–1,835 kboe/d updated range, with new oil in the Gulf of America and Brazil partly offsetting production-sharing effects and field decline.

"In August, our assets in the Gulf of America delivered the highest monthly production in over 2 decades." — Sinead Gorman, Chief Financial Officer

Segment operating cash flow of $7,281M included $908M of net joint-venture dividends and was struck after $2,577M of tax payments. The update note explains that $0.8B of the joint-venture dividend is offset by an outflow in Corporate working capital, so the group effect is nil. The Na Kika and Coulomb sale completed for about $840M and produced $777M of post-tax divestment gains.

Assessment: a soft quarter on the surface and a fine one underneath. Write-offs are the cost of the exploration restocking management keeps describing, and the tax line is lumpy. The one item to discount is the $341M elimination release, which flattered the segment and will reverse whenever liquids prices rise again.

Chemicals and Products

Adjusted earnings of $3,855M rose 34.0% sequentially and split $3,751M Products and $103M Chemicals. Products rose 48.7% from $2,523M; Chemicals fell 70.9% from $354M as the indicative chemicals margin dropped to $208/tonne from $270/tonne. The company attributes the increase to a $1,065M rise in Products margins on higher refining margins, partly offset by lower trading and optimisation, plus $230M of favourable tax. Refinery utilisation was 96% against 102% in Q2 because low Rhine water levels limited the Rheinland refinery; management put utilisation above 100% excluding Rheinland and at 99% for the year to date. Chemicals utilisation rose to 84%.

"In Products, record results were driven by another quarter of impressive refining performance as we achieved a utilization rate above 100% when excluding Rheinland, which was impacted by low Rhine water levels." — Sinead Gorman, Chief Financial Officer

Operating cash flow of $8,527M included $1,454M of derivative inflows and $1,239M of working-capital release.

Assessment: the October update note told the market the indicative refining margin was $42/bbl, so the size of this number was known; the quality of the capture was not, and the quality is high. The caution is in the same sentence of the release: trading and optimisation in this segment fell, against an October expectation that it would be in line with Q2. Products is being carried by the crack, and the CFO's October read was that the integrated refining margin had already "come down a little bit."

Marketing

Adjusted earnings of $1,164M fell 12.4% sequentially and 11.6% year-over-year. Margins fell $262M on weaker Mobility unit margins and lower Lubricants volumes, partly offset by $120M of favourable tax. Sales volumes of 2,581 kb/d rose 0.4% sequentially on seasonal Mobility demand. Below the adjusted line, the segment took a $1,904M post-tax impairment on European biogas assets after management reassessed "the pace of market development and associated value realisation," leaving income for the period at $55M.

Operating cash flow was an outflow of $210M, driven by $1,866M of emission-certificate and biofuel payment timing and $947M of working capital. In September Shell agreed to raise its stake in Tri Star Energy, a south-eastern US convenience operator, from 33% to 100%, adding 320 company-owned sites and supply to 552 dealer sites. The price was not disclosed.

"Thirdly, we announced the acquisition of Tri Star Energy, which more than doubles the number of company-owned convenience retail sites in the U.S." — Sinead Gorman, Chief Financial Officer

Assessment: two quarters running, the Marketing line has weakened beneath a flattering headline. Last quarter tax offset margin; this quarter tax offset part of it and the rest showed. The biogas write-down is a capital-allocation verdict on a low-carbon acquisition, and the Tri Star purchase is the opposite bet: convenience retail in the US Southeast, where Shell already supplies the forecourt.

Renewables and Energy Solutions

Adjusted earnings of $289M against $79M in Q2, on $141M of higher margins, "mainly from trading and optimisation," and $58M of favourable tax. The release again states that trading, energy marketing and renewable generation earned money while other activities lost it. Operating cash flow of $1,558M was driven by $1,913M of derivative inflows. Identified items included $147M of impairments. In the quarter Shell agreed to sell its European onshore renewables portfolio (about 0.5 GW) and its RISEC power plant interest for $715M, and to buy a 169 MW gas-fired plant in Pennsylvania.

Assessment: the segment's earnings are a trading result, as they were last quarter, and its cash flow is a derivative-margining result. The portfolio actions continue to shrink owned renewable generation, which is consistent with what management has said it is doing.

Corporate

A net expense of $705M against $617M in Q2 and $383M a year ago, on $82M of higher operating expenses and $76M of unfavourable tax, partly offset by $57M of favourable currency effects. That is $5M worse than the $(500)–(700)M range set in July and inside the $(600)–(800)M range the October update note substituted. Interest expense rose to $1,168M from $1,114M despite lower net debt, because lease liabilities carry interest too.

Assessment: the deleveraging that flattered Corporate in Q2 has stopped showing up, because the lease liability is growing faster than the financial debt is falling. The Q4 range of $(600)–(800)M accepts that.

Operating Metrics and Guidance Delivery

Shell set two sets of Q3 ranges: seven with the Q2 results on July 30, and a fuller set in the October 7 update note. The July set is the cleaner test of forecasting; the October set is the cleaner test of disclosure discipline, because it was issued with most of the quarter known.

The update note also guided pre-tax depreciation and the taxation charge for four segments, and four group cash-flow items. These cross-walk exactly to the results: the note's "pre-tax depreciation (as Adjusted)" is depreciation excluding impairments, and its "taxation charge (as Adjusted)" excludes the tax on identified items.

Twenty of twenty gradable October ranges landed inside. The four segment underlying-opex ranges cannot be graded, because Shell reconciles underlying opex only at group level. Two qualitative statements missed on the unfavourable side: Upstream well write-offs of $408M against "~$0.3 billion," and Chemicals and Products trading, which the note expected "in line with Q2" and the release reports as lower. Against the July set, every comparable volume range landed inside and Corporate missed by $5M. That $5M is the first downside miss on a quantified range in five quarters of coverage, and it is immaterial; we record it because the guidance-credibility argument depends on counting honestly.

Key KPIs

Indicative margins are the figures Shell published in its October 7 update note. The release does not restate them.

Key Topics & Management Commentary

Overall Management Tone: confident and, for the first time in our coverage, relaxed about the macro rather than defensive of it: the chief executive volunteered that he had misread the oil price six months ago. Distributions took most of the Q&A, and the answers were framework-level rather than numeric, with an explicit refusal to guide the Q4 buyback. This was the most expansive call of the five we have covered and the least specific on the two items deferred to February: the trading contribution and the 2027–2028 capital framework.

1. The $5.0B Buyback Is a Top-Up, Not a New Run-Rate

Shell completed the $4.2B programme announced in July and launched a $5.0B programme to run until January 29, split $3B on the London line and $2B on the Netherlands line, with a cap of 470M shares under the 2026 AGM authority. It is the twentieth consecutive quarter at or above $3B. Total distributions in the quarter were $5,335M, $3,183M of repurchases and $2,152M of dividends, against $21.0B of operating cash flow: a 25% payout in the quarter and 32.5% for nine months.

The framing is the news. The CFO described the extra $2B as a "top-up" and said she chose the word deliberately. Both executives tied it to keeping the 40–50% through-cycle payout band in reach, with the chief executive putting a floor under the band in plain language.

"We will always aim to keep pace, and you have seen us top up when we feel that we are starting to sort of fall below the 40% we are not structurally going to accept to be at the 30s percent." — Wael Sawan, Chief Executive Officer

On our estimate of $17–20B of fourth-quarter operating cash flow, 2026 distributions land at roughly 34–35% of CFFO, still below the band. Add 2025, when Shell paid out 52.1%, and the two-year figure is roughly 41%. That is the arithmetic behind "through the cycle," and it says the band is being managed over years, not quarters.

Assessment: the commitment got stronger and the number got less predictable in the same answer. A management team that says it will not "structurally" accept a payout in the 30s, in a quarter when the payout was 25%, has effectively promised further top-ups while Brent stays high. It has also told us the $3B base is what returns when the cycle turns. We model $3B as the base and treat anything above it as a price-linked variable.

2. Management Changes Its Mind on the Oil Price

The most important sentence on the call was not about Shell. Asked to reconcile the buyback with a promise not to be procyclical, the chief executive reversed the view of the market he held six months ago.

"I'd start off by saying, if you'd ask me 6 months ago, would I have thought that oil prices were going to be where they are today? No. I'll be honest with you. We -- I personally thought we were at a high there, and we're essentially looking at what was going to be a temporal spike. We're now seeing more and more structural stability in that higher oil price simply because we are seeing that inventory levels are being drawn down very quickly, and it's going to take quite some time to be able to refill that inventory, not to mention new inventory that countries will want to have for energy security purposes." — Wael Sawan, Chief Executive Officer

Brent closed at $110.80 on results day, down 3.9% on the session. The October update note put the Q3 indicative refining margin at $42/bbl.

Assessment: this matters for two reasons. It is the reason the top-up exists, because a management team that thought the spike was temporary would have kept the cash. And it is a forecast from a company that, by its own account, got the last one wrong. We take the inventory argument seriously and lengthen our assumed unwind accordingly in the model below. We do not adopt the conclusion: a price that management now calls structurally stable is still a price, and Shell's own sensitivities make its earnings a function of it.

3. $21.0B of Operating Cash Flow, Pulled Two Ways by Timing

Operating cash flow of $21,043M was 1.8% below Q2 and free cash flow of $16,322M was 6.9% lower, but the headline hides two timing items of opposite sign. Derivative cash movements added $3,435M, which the CFO attributed to "effective risk management." The early payment of $2.4B of German fuel-emissions certificates, normally a Q4 item, took $2,189M out through the emission-certificate and biofuel line. Working capital was a further $638M outflow.

Tax is the third timing item and the one that runs into next year. Shell's adjusted taxation charge was $5,021M in the quarter and its tax paid $3,217M; across nine months the gap is $5,086M.

"So you'll see that start to catch up as things go through. But it's just timing of price versus where the actual tax has been paid." — Sinead Gorman, Chief Financial Officer

Assessment: excluding the derivative inflow, operating cash before working capital was flat sequentially at about $18.2B while adjusted earnings rose 9.9%. That is not a warning sign; it is the tax lag and the emissions-certificate pull-forward in the same quarter. The useful number to carry forward is that roughly $5B of accrued tax is owed and unpaid, and it will show up as a cash-conversion drag in Q4 and early 2027 just as the refining margin eases.

4. $16.3B of Free Cash Flow, $2.0B of Deleveraging: The Lease Line

Net debt fell $2,021M to $39,733M. The bridge in the release is free cash flow of $16.3B, less $6.6B of lease additions, $3.2B of buybacks, $2.2B of dividends and $2.5B of net debt and leases assumed with ARC. The lease additions are the unusual item: $5.4B is a non-cash increase in the variable component of shipping leases, which IFRS 16 requires Shell to remeasure at spot freight rates. Lease liabilities are up $7,684M for the year from that index effect alone.

"Since the end of last year, we have reduced net debt by $6 billion with gearing at 17% at the end of Q3 or less than 3% when excluding leases." — Sinead Gorman, Chief Financial Officer

Assessment: management chose the ex-lease figure for the prepared remarks, and on this occasion it is the right one. Net debt excluding leases is $5,586M against $90.9B of annualised Q3 adjusted EBITDA. The lease liability is real, it carries interest, and it will rise again if freight stays where it is, but it is a mark on a contract Shell already holds, not borrowing to fund the distribution. Our Bear 2 point is answered for a second consecutive quarter.

5. ARC Closes: $14.0B, 228M Shares and One Month in the Numbers

ARC completed on September 2, within six months of the start of discussions by management's account. The consideration was $14,008M: $10,601M in 228.0M new Shell shares (4.1% of the shares outstanding at June 30), $3,336M in cash and a $71M hedge result. Equity value rose from $13.6B at announcement because Shell's own share price rose. Goodwill of $2,169M is provisional. ARC adds about 370 kboe/d and accounts for most of the 22% rise in Integrated Gas production with one month of contribution.

"It's 1 month into the portfolio." — Sinead Gorman, Chief Financial Officer

Management deferred any ARC operating or cash milestones to the February Capital Markets Update or mid-2027.

Assessment: the transaction closed on time, on terms and with a lower gearing than before it. The Q4 Integrated Gas guide of 1,080–1,180 kboe/d is the first full-quarter test. The return standard management set in July, double-digit with an aspiration to "mid-double-digit", now has a closing date to be measured from.

6. LNG Canada Phase 2 Is Sanctioned, and an Asset Is Written Back Up

Shell took FID on LNG Canada Phase 2 in September. The expansion doubles the plant to 28 mtpa, with Shell's 40% share bringing nearly 6 mtpa of additional LNG and first commercial operations expected in the early 2030s. The same decision, together with changed commercial terms, triggered a $1,787M pre-tax impairment reversal on a North American Integrated Gas asset.

"I think part of your question, Fergus, was almost what's the upside to LNG Canada Phase 2 FID. We didn't bank that into our premise -- into our thesis for the ARC acquisition. That will be upside." — Wael Sawan, Chief Executive Officer

The CFO added that contractor pricing was "much more competitive" because Phase 2 extends an existing facility rather than building a new one.

Assessment: the FID was the Phase 2 commitment management made in July ("likely to be before end of this year"), delivered ahead of that timeline. It is a long-dated volume addition, not a 2027 earnings item. Its near-term significance is that it lifts the value of the gas Shell just bought with ARC, and that the accounting already reflects it through the reversal.

7. Products Sets a Record on a $42 Refining Margin

Products earned $3,751M, up 48.7% sequentially, on an indicative refining margin of $42/bbl against $24/bbl. Refinery utilisation was 96%, 99% for the year to date, and management put it above 100% excluding the Rhine-constrained Rheinland site. The structural explanation is the same trader-operator model management described in July, now extended across the system.

"Today, you effectively have our traders sitting in the asset with single point commercial accountability for the entire value chain from feedstock purchase all the way to product distribution, responding to market signals such as, for example, today, it's more around diesel and kero, maximizing those cuts and looking to optimize margin." — Wael Sawan, Chief Executive Officer

Management named records in diesel at Pernis and in jet and kerosene at Scotford, and said the work is "not yet at where we need it to be."

Assessment: we keep the July split. Utilisation is durable and controllable; the crack is neither. The October commentary is the first sign of the second half of that sentence: the integrated refining margin "come down a little bit," and freight costs are now eating into realisations.

8. Chemicals: $103M, Cash-Positive, and "Deep Discussions"

Chemicals earned $103M against $354M in Q2 as the indicative chemicals margin fell to $208/tonne, but was free-cash-flow positive for a second consecutive quarter. The US chemicals exit, which went silent in July, came back on the record when an analyst asked whether now is the time to sell.

"If we cannot find a mid-cycle set of margin conditions between us and the buyers, then the more likely outcome could be something where we combine portfolios, take equity interest in -- a minority equity interest in something else, and look to be able to ride the wave until we feel it's the right time to be able to monetize the asset." — Wael Sawan, Chief Executive Officer

A separate question raised press speculation about Infineum; management declined to comment on specific assets and restated that it is "not the natural owner" of chemicals.

Assessment: this is a better answer than silence, and a more realistic one than a clean sale. A combination with a minority retained stake is the structure most likely to clear a buyer and seller who disagree on mid-cycle margins, and it would take chemicals out of the capital-employed base without crystallising a trough price. We now treat a chemicals transaction in 2027 as more likely than not.

9. Marketing: A $1.9B Biogas Write-Down and a US Retail Bet

The $2,116M pre-tax impairment on a European biogas asset is the largest single charge of the quarter, and the notes put it down to slower market development. In the same quarter Shell agreed to take Tri Star Energy to full ownership, adding 320 US convenience sites. Management framed the moves as reallocating capital from non-core positions into businesses where Shell has an advantage.

"Our marketing business performed well despite experiencing a lower margin environment." — Sinead Gorman, Chief Financial Officer

Assessment: the description is generous. Adjusted earnings fell 12.4%, operating cash flow was negative, and the segment's largest low-carbon acquisition was written down. The reallocation logic is sound and the Tri Star deal fits it, but the price went undisclosed, and a segment that missed on margins for a second quarter is the one where we would most like to see the number.

10. Upstream and the Resource Base: "Largely Derisked" to 2030

Upstream had its weakest sequential quarter of the year on write-offs and tax, while management spent more time than in any prior call on resource depth: ARC, LNG Canada Phase 2, Bay du Nord (Equinor-operated, FID targeted early next year), Bonga South West (FID possible "by next year, if all the stars align"), and exploration results in the Gulf of America and Namibia.

"2030, as we have said in the past, is largely derisked. If I look into 2035, we're making very good progress." — Wael Sawan, Chief Executive Officer

Assessment: at the Q4 2025 print we flagged reserve replacement as an emerging bear point, with the post-2035 gap conceded and undated. This quarter added real barrels through ARC and real capacity through Phase 2, and the language moved from "conceded" to "very good progress." The February update is where this gets a number; until then we treat the resource concern as easing, not resolved.

11. The Conflict's Second-Order Costs: Pearl, Lubricants and Freight

Shell is still absorbing the Gulf disruption in three places. One Pearl GTL train has partially restarted but cannot ship. Lubricants volumes are lower because Pearl supplies the base oil, and the team built an overland route across several countries to keep customers supplied. And freight on the Middle East to China route is, in the CFO's words, ten times what it was a year ago, which is now pushing down realised margins.

"So on Qatar, what's important to recognize is we're starting to see on the Pearl GTL side, we have partially restarted one of the trains. Don't expect much in terms of cash flow or earnings at this stage. We're filling up the inventory there." — Wael Sawan, Chief Executive Officer

The damaged second train remains "planned for late in Q1," subject to the Strait of Hormuz reopening.

Assessment: Bear 3 is no longer a binary; it is a running cost the integrated model is absorbing, offset by the price environment the same conflict created. Unlike the July range, the Q4 Integrated Gas range does not say whether it includes Qatari volumes, while management says the LNG impact continues into Q4.

12. Capex Cut by $1B, and February 4 Becomes the Date for Everything Deferred

Full-year 2026 cash capital expenditure is now $23–25B, down from $24–26B, still including about $4B for ARC. Nine-month spend was $16,361M, which implies $6.6–8.6B in Q4. The CFO said the cut was mostly timing and phasing. The Capital Markets Update, previously "some point in the first half of 2027," is now February 4, alongside the Q4 results.

"Our cash CapEx range for 2026 is now between $23 billion and $25 billion, which includes some $4 billion for the acquisition of ARC Resources." — Sinead Gorman, Chief Financial Officer

February 4 now carries the trading disclosure, the ARC value update, the 2027–2028 capital framework, the resource outlook and, implicitly, any change to the distribution framework.

Assessment: a lower capex number in a year that absorbed an acquisition and sanctioned a major project is a good outcome, even if most of it is phasing. The concentration of disclosures on a single date is the bigger point: every open question in our thesis now resolves on February 4, which makes it the stock's next real catalyst in both directions.

Guidance & Outlook

The Q4 ranges are the first to include a full quarter of ARC, and the Integrated Gas step from 772 to a 1,130 kboe/d midpoint is mostly that. Everything downstream is guided flat to lower: Marketing volumes 3.1% below Q3 at the midpoint, refinery utilisation flat at 96% at the midpoint, chemicals two points lower. The CFO's qualitative color pointed the same way: October refining margins slightly below Q3, freight pressure on realised margins, hurricane exposure in the Gulf of America, and no Pearl volumes until Q1.

The Q4 tax line: Shell's fourth quarter carries an annual non-cash reassessment of deferred taxes, and its Q4 adjusted effective tax rate was 46.8% in 2025 and 47.2% in 2024, against 31.7% this quarter. Q3 adjusted pre-tax income was $15,849M. Even with pre-tax income held at $13.5–15.0B, a high-forties rate produces Q4 adjusted earnings of roughly $7.0–8.0B. Any Q4 estimate built on the Q3 rate will be too high, and we made that mistake ourselves a year ago.

The Q4 identified items: the Dutch pension fund's move to defined contribution, expected at December 31, will produce a non-cash identified loss currently calculated at $6.4B. It sits below adjusted earnings and has no cash effect, but it will dominate the Q4 IFRS income line.

Implied H2 capex: the new range implies $14.6–16.6B across the second half against $15.6–17.6B under the July range, with Q3 at $7.9B including $3.2B of inorganic spend.

Street at: the company-compiled consensus published October 21 had full-year 2026 adjusted earnings at $36,664M and 2027 at $31,823M, on Brent assumptions of $92.1 and $81.0. With the Q3 actual in place of the estimate, the full-year figure implies about $9.1B for Q4, above our $8.0–9.0B range; the difference is the Q4 tax rate. Our 2027 estimate of $28.0B sits 12% below the consensus.

Guidance style: conservative on volumes, and now pre-announced in detail. The October update note gave twenty quantified ranges three weeks before the print and the quarter landed inside all of them, so the "beat" on the day was against analysts' estimates, not against anything the company had not already told the market.

Analyst Q&A Highlights

Squaring a $5B Buyback With a Promise Not to Be Procyclical

The second question of the call went straight at the tension. At the Q1 print, with oil higher and the shares about 20% lower, management trimmed the buyback and talked about not being procyclical; now, with the shares higher, it has raised it. Management answered with a framework: at cycle peaks Shell aims for the bottom of the 40–50% band while strengthening the balance sheet, at troughs the top of it, and the $5B was the minimum needed to stay near the band this quarter.

Q: "But forgive me, whilst I'm not criticizing your generosity, I'm just struggling to understand today's announcement on buyback or at least how you think about the conflicting aspects of your statements? So how do you square the circle with putting the balance sheet and awaiting better value opportunities, be they your own equity or other investment opportunities not have been a more appropriate value decision?"
— Lucas Herrmann, BNP Paribas

A: "If we hadn't, of course, done a $5 billion, we would have been at the $3 billion. So that top of that extra $2 billion, we would have been closer to the sort of 30%, et cetera. It's much more of an art than a science, of course, but that keeping pace is very, very key to us."
— Sinead Gorman, Chief Financial Officer

Assessment: the answer was internally consistent and did not address the valuation half of the question. Management's own position is that the band governs the total and the split between dividend and buyback is "art more than science." That makes the buyback a residual of operating cash flow, which is exactly what the question was worried about at a 43% year-to-date share price gain.

Whether $5B Is a Signal for 2027

A follow-up asked directly whether the $5B was a catch-up on cash already earned or a signal of future distributions. The CFO confirmed the "top-up" wording was chosen deliberately and declined to guide the fourth quarter, then placed the decision inside a longer record of averaging 40–50% across the current chief executive's tenure.

Q: "So to what extent is this decision to get to $5 billion a sort of catch-up from cash flow you've already received or generated this year versus actually what is a signal for what could be future cash flow or future distributions looking into 2027?"
— Joshua Stone, UBS

A: "And that meant we were very comfortable topping up from the $3 billion to the $5 billion. And you spotted my use of the word top-up indeed, and it was thoughtfully given. So whilst I wouldn't guide towards the fourth quarter in any way, I would say what we're trying to do is to always sort of dampen the effect of the cycle and to give that 40% to 50% to our shareholders with some consistency, and we've been building that track record."
— Sinead Gorman, Chief Financial Officer

Assessment: the clearest answer on the call, and a deliberately limiting one. "Top-up" is a catch-up word, and the refusal to guide Q4 keeps the $3B base intact. Anyone capitalising $5B a quarter into a valuation is ignoring a CFO who told them, in terms, not to.

Whether Now Is the Time to Sell Chemicals

The question accepted that Shell wants out of chemicals and asked whether a cash-rich company should transact now, given a history of poorly timed disposals. The answer set out a value-first test, described the 2030 horizon as a way to avoid a forced sale, and for the first time described a fallback: combining portfolios and retaining a minority stake. It also confirmed active talks.

Q: "There's been a lot of press around you shopping various chemicals assets. We sort of know your long-term intentions in chemicals are clear. My question is more around whether now is the right time to transact? You obviously don't need to sell anything from a financial balance sheet point of view."
— Biraj Borkhataria, RBC Capital Markets

A: "We are in deep discussions. I won't comment on who and what at this stage other than to say we continue to progress those discussions and expect to do so in the coming months."
— Wael Sawan, Chief Executive Officer

Assessment: a process that went silent in July is now on the record as "deep discussions" with a timetable of months. The answer also conceded the analyst's point implicitly: two quarters of positive free cash flow and a Monaca track record are being built to support a price, which means the company itself thinks a sale at last year's margins would have been too cheap.

What the $1B Capex Cut Is Made Of

The final question of the call asked how much of the cut was timing and how much efficiency, and whether it read across to the 2027–2028 framework. The answer was short and mostly timing, and it restated the ARC absorption commitment that went unrepeated in July.

Q: "How much of that reduction came from timing versus real capital efficiencies or lower underlying spend? And then is there any read across from that into the '20 to '22 annual CapEx framework for '27, '28, either on the upside or the downside?"
— Kim Fustier, HSBC

A: "So indeed, we brought it down by roughly $1 billion. A large part of that is really timing and phasing with a few efficiencies built in. So it's a bit of a blend in there. In terms of the read across, I think the only thing I would say is really, Kim, we've talked about the fact that we will absorb ARC into our existing CapEx guidance. We still believe that, that is true."
— Sinead Gorman, Chief Financial Officer

Assessment: this exchange clears the item we called the most consequential number Shell did not repeat in July. It is a restatement in words rather than figures, and the figures come on February 4, but a CFO who says "we still believe that, that is true" on the record has set the bar the framework will be graded against.

Freight Rates: Access, Cost and the Q4 Margin Squeeze

A question about Shell's tanker book drew a three-part answer: Shell's large chartered fleet secures access, spot costs are sharply higher, and the trading desk can make money around the dislocation. The CFO was candid that spot freight is now squeezing refining, chemicals and oil margins, and in a later answer said October integrated refining margins were slightly below Q3 with lower realisations likely this quarter.

Q: "First, on the trading side, I was wondering if you could give us a bit more visibility on your tanker portfolio, how much of that you've got locked in at long-term rates and how much you're paying on spot given the extraordinary increase in freight rates we've seen in the last few months, and how this is likely to impact your realizations, but also probably on the positive side, your trading business in the fourth quarter?"
— Michele Della Vigna, Goldman Sachs

A: "And actually, we were talking about it earlier, just that route between sort of anywhere in the Middle East and China at the moment is 10x what it was from even just 12 months ago as well or in 2025 full stop. So you absolutely see that. And you see that starting to come into margins. We even see the pressure on our own side in terms of the refining margins as well."
— Sinead Gorman, Chief Financial Officer

Assessment: the answer put a cost on the conflict that does not appear in any guided range. Freight is now a headwind to Q4 realisations and a tailwind to the trading book, and management would not size either side. It is also the same variable that is inflating the lease liability, so it touches the income statement, the cash flow and the balance sheet at once.

Leases Marked to Spot, and the $3.4B Derivative Inflow

Two analysts returned to the lease line. One noted that the pace of lease additions had not slowed as the 2025 Capital Markets Day suggested; the other asked whether the remeasurement assumes spot freight for the full lease tenor even though freight forwards are steeply backwardated. The CFO confirmed the spot-rate treatment, called it an accounting result rather than an economic one, and attributed the derivative inflow to risk management with "ebbs and flows" from margining.

Q: "But I was wondering about that because the sort of the number in billions is reasonably material."
— Multiple analysts incl. Martijn Rats, Morgan Stanley; Doug Leggate, Wolfe Research

A: "Just the way it gets accounted for is the fact that we actually have to use the spot rate as an indicative of where it goes through the life of -- or the tenure of the leases, which is something that I think it's not just us. You've seen some of the trading houses object to us and make comments on it as well. Deeply frustrating."
— Sinead Gorman, Chief Financial Officer

Assessment: the analyst's point stands and management agreed with it. If spot freight holds, the liability rises again; if it falls, it shrinks, and either way net debt moves for reasons unrelated to operations. We will track net debt excluding leases as the operating measure and lease liabilities separately.

How Long Refining Can Run This Hard

A question on several quarters of very high utilisation asked what else explains it and what it implies for the 2027 turnaround schedule. The answer named safety-led maintenance as the baseline, trader integration as the main change, and data and AI for early intervention, and said the system is not yet where it needs to be.

Q: "And then second question on refining. Very high utilization rates now for several quarters. It's quite impressive considering history. You've talked about great integration of trading, I think, on the Gulf Coast. Are there some other factors you want to highlight there? And how should we think about implications for refinery maintenance and potentially as you look into 2027 and the turnaround schedule then?"
— Joshua Stone, UBS

A: "We are now at records in our diesel production. Pernis, for example, in the Netherlands, got to a record just in August. Scotford in Canada got to a record in jet kero production. So really getting the most out of these assets."
— Wael Sawan, Chief Executive Officer

Assessment: the answer was specific on performance and silent on the 2027 turnaround schedule, which was the forward half of the question. Utilisation of 99% year to date has been earned, but a year of high runs is also a year of deferred wear, and the Q4 utilisation range of 92–100% is the only forward signal offered.

M&A After ARC

A question asked whether volatile prices make this a poor time for deals and, with hindsight, what management learned from trimming the buyback at the Q1 print. On M&A the chief executive said nothing currently meets the bar; on the buyback the CFO said Shell has bought back about 30% of the company over the last few years.

Q: "Wael, I've got one question on M&A. You were telling us not so long ago that you're spending an increasing amount of time on what's coming through your desk. What are your sense is telling you right now?"
— Christopher Kuplent, Bank of America

A: "Even if we look at 100 of these companies, it's very rare to get even one of them sort of screening through. And indeed, ARC met that high bar. If I'm honest with you, I don't see an obvious target at the moment that's meeting that high bar."
— Wael Sawan, Chief Executive Officer

Assessment: the most reassuring answer on the call for the distribution case. At the Q4 2025 print we called capital reallocation the largest thesis risk inside management's control. A chief executive with a near-unlevered balance sheet who says he sees no obvious target, and elsewhere says surplus cash will not "burn a hole through our pockets," has lowered that risk for now.

What They're NOT Saying

1. The $6.4B pension loss coming in Q4. Note 7 calculates a $6.4B non-cash identified loss on the Dutch pension fund's move to defined contribution at December 31. It was not mentioned in the prepared remarks or the Q&A. It has no cash effect, but it will be the largest line in the Q4 IFRS result, and it arrives in the same release as the Capital Markets Update.
2. How much of the cash beat was trading. The CFO named three drivers of the quarter's cash: operational performance, "great contribution from our trading colleagues" and risk management. None was sized. Disclosure is now dated to February 4, and the derivative inflow alone was $3.4B.
3. The Q4 buyback. "So whilst I wouldn't guide towards the fourth quarter in any way." With 2026 distributions tracking at roughly 34–35% of operating cash flow even after the top-up, the arithmetic argues for another, and management declined to say so.
4. The working capital that never came back. In May management committed to reversing "a significant amount" of the Q1 build. Nine months in, the cumulative outflow is $8,372M, Q3 added $638M to it, and nobody asked. At $110 Brent it may never come back, and that is a reasonable outcome, but it is not the one management described.
5. The size of the cash-tax catch-up. The CFO confirmed the lag and named Norway's December payments. The release arithmetic puts the nine-month gap between adjusted tax charged and tax paid at about $5.1B; the call gave no figure.
6. The cost programme. Shell reports cumulative structural cost reductions at the half year and full year, so no update was due. But the $5–7B target went unmentioned on a call that ran long on performance, while underlying operating expenses rose 4.7% sequentially to $8,836M, part of it a month of ARC.
7. Raizen. The Brazilian joint venture's restructuring plan carries a contingent capital injection and an automatic termination date of March 31, 2027. It did not come up.

Market Reaction

• Pre-print setup: the ADR closed at $105.19 on October 28, up 43.2% year-to-date against 13.1% for the S&P 500, up 39.2% over the trailing twelve months and up 10.6% over the trailing thirty days. The 52-week closing range entering the print was $70.31 to $108.18, so the shares went in 2.8% below their high.
• Reaction session (October 29): the ADR opened at $108.02, a 2.7% gap up, traded a $107.03 to $108.27 range and closed at $107.67, up 2.4% or $2.48. The S&P 500 fell 0.3% and Brent fell 3.9% to $110.80 on the same session.
• Volume: 7.4 million ADS against a 30-day average of 6.1 million, 1.2 times normal.
• Peers: BP rose 1.1%, TotalEnergies 1.2% on its own beat the same morning, ExxonMobil 0.7% and Chevron 1.0%; Equinor fell 0.2%. The five-peer average was +0.8%, so Shell outperformed by about 1.6 points.
• Next session (October 30): the ADR rose a further 0.95% to $108.69, a new 52-week closing high, while the S&P 500 fell 1.82% and BP, ExxonMobil and Chevron all reported beats.
• Since our last note: the ADR closed at $90.51 after the Q2 print on July 30; the reaction close of $107.67 is 19.0% higher.

The tape rewarded the distribution, not the earnings. The beat against the company-compiled consensus was 4.7%, against 10.3% in July, and the shares rose 2.4% on a day when crude fell almost 4% and the market fell. The wire coverage led with the buyback, and the move has the same shape as July's: the market is paying for cash returned, and it has done so three quarters running. In May an 8.7% beat with a weak cash statement drew a 3.4% decline; in July an 11.9% beat with a restored buyback drew a 2.5% gain; now a smaller beat with a larger buyback drew a similar gain.

The second session matters as much as the first. A 2.8-point outperformance of the S&P 500 on October 30, on the day the US majors printed beats and hit all-time highs, says this was not one stock's news but a sector being re-rated on refining profits and returns. Shell was simply first of the large majors to put a bigger number on the distribution.

The level is what changes our view. At $107.67 the shares have moved through our $100 target, trade at a new high, and sit at roughly the average target across the Street. The market has stopped treating Shell as the discounted major we initiated on at $74.73.

Street Perspective

Debate: Is $5B the new buyback run-rate?

Bull view: the payout was 25% of operating cash flow in the quarter and is tracking in the mid-30s for 2026 even after the top-up, and management has said it will not accept a payout in the 30s. Some desks now model $5B a quarter through the first half of 2027, and see room for a meaningful dividend increase at the February strategy update.

Bear view: management called it a top-up and refused to guide Q4. One estimate circulating on the Street puts the oil price needed to sustain $5B through 2027 at about $80, other models ease the buyback to $4B in the second half of 2027, and Q4 brings a tax catch-up and a high seasonal tax rate.

Our take: both sides agree on the mechanism and disagree on the oil price. The distribution is now explicitly a function of operating cash flow, so the buyback is a derivative of Brent with a $3B floor. We model the floor and treat the top-up as a price option. A dividend increase in February would be the more durable signal, and we would weigh it more heavily than any single buyback.

Debate: Is the refining windfall durable?

Bull view: inventories are depleted, Middle East supply is disrupted, and strikes on Russian refineries have tightened products further; the record $42/bbl margin is an industry result, not a Shell result, and peers printed similar indicator margins. Management itself now calls the higher price environment structurally stable.

Bear view: refining margins rarely last at records. The October margin was already lower, freight costs are now eating realisations, and the company-compiled consensus itself has Chemicals and Products earnings roughly halving in 2027.

Our take: the bears are right about the level and the bulls about the duration. We do not capitalise a $42 crack, and we do lengthen the unwind: our 2027 estimate moves to the top of our through-cycle range rather than below it. The utilisation gains are the durable part, and they are already in the base.

Debate: Has the valuation gap closed?

Bull view: at $107.67 the shares trade at about 9.3 times the company-compiled 2027 consensus, the balance sheet is close to unlevered outside its leases, and by the company's count Shell's total shareholder return since the end of 2022 is ahead of every large peer. The February update is a catalyst that can only add disclosure.

Bear view: the stock is up 43% this year, sits at the average Street target, and half of the Street is at a neutral rating. The consensus that makes it look cheap assumes an $81 Brent average for 2027, and the February update could just as easily show what the trading contribution is worth at a lower price.

Our take: the gap that justified our Outperform has closed. The discount we bought at initiation was a discount to peers and to normalised earnings, and both have narrowed. What is left is a fairly priced, well-run major whose next twelve months depend more on the oil price than on anything Shell controls, which is the definition of a Hold in our framework.

Model Update & Valuation Framework

Valuation

At the October 29 close of $107.67, the 5,729.5 million ordinary shares outstanding at September 30, equivalent to 2,864.7 million ADS, capitalise the equity at approximately $308.4B. Against that:

• Dividend yield 2.90%, on the $0.7812 quarterly ADS dividend annualised to $3.1248.
• Buyback yield 6.48% if $5.0B a quarter is sustained for a year, or 3.89% on the $3.0B base.
• Combined shareholder yield about 9.4% at the top-up pace, or 6.8% on the base, against 8.2% at our July note on a share price 19% lower.
• Trailing multiple 9.8x, on $10.96 per ADS of adjusted EPS over the last four quarters ($5.48 per ordinary share).
• Forward multiple 10.6x our 2027E of $10.14 per ADS, and about 9.3x the company-compiled 2027 consensus.
• Leverage 0.44x net debt to annualised Q3 adjusted EBITDA, or 0.06x excluding $34.1B of lease liabilities.
• ROACE 14.4%, against 12.4% in Q2 and 9.4% a year ago.

The base case puts 2027 at the top of our through-cycle range: the refining margin falls back toward mid-cycle over the year, trading settles inside its 2–4% ROACE band rather than at the top, ARC contributes a full year, and buybacks run at the $3B base with top-ups early in the year. The bear case needs Brent back in the $60s with the crack at mid-cycle and trading at the bottom of its band. The bull case is close to the company-compiled consensus with a higher multiple: Brent holding in the $90s through 2027 and the February update sizing the trading contribution at the top of its range.

Our twelve-month price target rises to $112 from $100, implying 4.0% price appreciation and roughly 6.9% total return with the dividend. The target rises because the earnings base rises; the multiple does not. The rating falls because the price rose further: 19% since July against a 12% increase in our target.

Thesis Scorecard Post-Earnings

The July Checklist, Graded

Overall: the business strengthened and the case for owning it at this price weakened. Five of six pillars held or improved: ARC closed on terms, Phase 2 was sanctioned, the balance sheet is near-unlevered outside its leases, the distribution grew, and the 2027–2028 capital framework was restated. The sixth, the de-rated multiple, has been used up by the share price. Neither of our published downgrade triggers fired: the buyback is $5.0B against a $3.0B floor, and the capital framework was restated with ARC inside it. This downgrade is about valuation alone. Conviction moves to 6 from 7, because the rating now depends more on the oil price than on anything we can grade.

Action: hold, and do not chase. We would move back to Outperform on either of two things: a pullback toward $97, which would restore roughly 15% upside to our target, or a February 4 update that sizes the trading contribution at a level supporting a through-cycle base above $28B, alongside a 2027–2028 capital framework at or below $22B with ARC inside it. We would move to Underperform if the buyback falls back to $3.0B while Brent holds above $90, which would put the payout in the 30s that management says it will not accept, or if the capital framework comes in above $22B.

Bottom Line

We initiated on Shell at $74.73 a year ago on three arguments: a cost programme that needed no help from the oil price, a shrinking share count, and a balance sheet that could carry the distribution through a weak cycle. We added a fourth in July, that the balance sheet was a year ahead of plan. All four are now on the record. The shares closed at $107.67 after this print, up 44% from initiation, and through the $100 target we set in July.

The quarter itself was strong and almost entirely pre-announced. Adjusted earnings of $10,814M beat the company-compiled consensus by 4.7% and the independently compiled one by 9.0%; the October update note had already put the refining margin at $42/bbl, and Shell landed inside every one of the twenty ranges in that note. Every headwind management warned of in July arrived, and a record crack paid for all of them. That is a good result and a macro result, and the composition says so: crude and products trading fell, and Products rose 48.7% on margin.

What changed in the case is the distribution. A $5.0B top-up and a chief executive who will not "structurally" accept a payout in the 30s make the buyback a function of operating cash flow above a $3B floor. That is shareholder-friendly and it is procyclical by design. At Brent near $110 it is generous; at Brent in the $60s, the payout band pushes the buyback back to the floor and the yield falls with it.

Against a share price that has caught up, the remaining upside to our raised target is 4%. The earnings base we are willing to capitalise moved up 14% this quarter; the price moved up 19%. The company-compiled consensus sits 12% above our 2027 estimate on an $81 Brent deck, and if that deck is right the shares are still cheap. We do not underwrite it. February 4 is the next test: the trading number, the capital framework, the ARC returns and, quite possibly, a higher dividend all land on the same day. Downgrading to Hold, price target to $112.